Group 1: Core Views - Multiple A-shares are set to resume trading, including Dongtu Technology and Weigao Blood Purification, following significant asset restructuring announcements [1][5] - Dongtu Technology plans to acquire 100% of Gaoweike, with the transaction expected to meet the criteria for a major asset restructuring [2][4] - Weigao Blood Purification intends to purchase 100% of Weigao Puri, also anticipated to constitute a major asset restructuring [5][6] Group 2: Dongtu Technology - Dongtu Technology will issue shares and pay cash to acquire Gaoweike, which will become a wholly-owned subsidiary post-transaction [2] - The share issuance price is set at 18.56 yuan per share, representing 80% of the average trading price over the previous 120 trading days [2] - The acquisition aims to enhance Dongtu's capabilities in providing comprehensive solutions and improve its market competitiveness [4] Group 3: Gaoweike Overview - Gaoweike, established in 2001, specializes in industrial automation and control systems, serving various manufacturing sectors [3] - The company has developed core products in motion control, including PLCs and servo systems, and has a broad customer base across China [3] Group 4: Weigao Blood Purification - Weigao Blood Purification's acquisition of Weigao Puri will expand its product line into pre-filled drug delivery systems and automatic safety delivery systems [7] - The company reported a total revenue of 2.736 billion yuan for the first three quarters of the year, reflecting a year-on-year growth of 3.45% [7]

Core Viewpoint - Multiple A-shares are set to resume trading, with significant asset restructuring announcements from Dongtu Technology and Weigao Blood Purification [1][6] Group 1: Dongtu Technology - Dongtu Technology plans to acquire 100% of Gaoweike through a combination of issuing shares and cash payments, with the stock resuming trading on November 3 [2] - The acquisition is expected to meet the criteria for a major asset restructuring, with the share price set at 18.56 yuan per share, which is 80% of the average trading price over the last 120 trading days [2] - Gaoweike, established in 2001, specializes in industrial automation and control systems, serving various sectors including new energy batteries and consumer electronics [3] - The acquisition aims to enhance Dongtu Technology's capabilities in providing comprehensive solutions and improve its competitiveness in the market [4] - In the first three quarters of 2025, Dongtu Technology reported a revenue of 500 million yuan, a year-on-year decrease of 11.72%, primarily due to a strategic shift in business structure [4] - New business segments, including smart controllers and industrial operating systems, showed significant growth, with order amounts increasing by 87.55% and 13.63% respectively [4] - Dongtu Technology is also strategically investing in the embodied robotics sector, indicating a broader focus on technological advancements [5] Group 2: Weigao Blood Purification - Weigao Blood Purification intends to acquire 100% of Weigao Puri through a share issuance, with the stock also resuming trading on November 3 [6] - The acquisition is anticipated to constitute a major asset restructuring, with the valuation and transaction price yet to be determined [6] - Weigao Puri, founded in 2005, is a leading manufacturer of pre-filled syringes, holding over 50% market share in China and ranking among the top five globally [6][7] - Post-acquisition, Weigao Blood Purification will diversify its business to include the development and production of medical packaging products, enhancing its resilience and growth potential [7] - For the first three quarters of this year, Weigao Blood Purification reported total revenue of 2.736 billion yuan, a year-on-year increase of 3.45%, with a net profit of 341 million yuan, up 7.92% [7]

为使本基金管理人旗下基金对长期停牌股票等没有市价的投资品种的估值更加公平、合理，根据《中国 证监会关于证券投资基金估值业务的指导意见》（证监会公告[2017]第13号），并参照中国证券业协会 《关于发布中基协（AMAC）基金行业股票估值指数的通知》（中基协发[2013]13号）的有关规定，经 与基金托管人协商一致，本基金管理人旗下基金自2025年10月29日起，对所持有的东土科技（300353） 采取指数收益法进行估值。本基金管理人将在该股票复牌且其交易体现活跃市场交易特征后，对其恢复 收盘价估值，届时不再另行公告。 2025年10月31日 特此公告。 兴证全球基金管理有限公司 ...

Suspension and Resumption of Trading - Dongtu Technology plans to acquire 100% of Gaoweike, leading to the resumption of its stock trading. Gaoweike provides automation control solutions to manufacturing clients across various sectors including new energy batteries, photovoltaics, automotive, consumer electronics, environmental protection, and printing packaging [1] - Weigao Blood Purification intends to purchase 100% equity of Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd., resulting in the resumption of its stock trading [1] - Zhongyuan Co., Ltd. will have its actual controller changed to Zhu Shuangquan, Zhu Shunquan, and Zhu Mengqian, leading to stock resumption [2] - Gongjin Co., Ltd. will have its controlling shareholder changed to Tangshan Industrial Control, resulting in stock resumption [2] Mergers and Acquisitions - Lanke High-tech has changed its major asset restructuring plan to propose acquiring 51% equity of China Air Separation [3] Investment Cooperation and Operational Status - Tianhua New Energy's actual controllers, Pei Zhenhua and Rong Jianfen, plan to transfer 12.95% of their shares to CATL at a discount of 19% compared to the closing price [4] - Shengxin Lithium Energy intends to introduce Zhongchu Innovation and Huayou Holding Group as strategic investors, raising no more than 3.2 billion yuan [5] - Vanke A has signed a framework agreement with Shenzhen Metro Group, allowing for a loan limit of up to 22 billion yuan [6] - Zhenyu Technology plans to invest 2.11 billion yuan in the construction of humanoid robot precision modules and components [7] - New Times has completed the deployment of humanoid robots on the production line at Haier's Chongqing refrigerator factory [8] - Pingzhi Information's invested Future Partner has launched a series of intelligent robot products [9] - Lepu Medical's subsidiary has signed a licensing agreement with Denmark's Sidera, acquiring 9.99% equity and up to 1.01 billion USD in milestone payments [9] Sales and Production Updates - BAIC Blue Valley's subsidiary sold 30,542 vehicles in October, a year-on-year increase of 112.02%. Cumulative sales for the year reached 142,043 vehicles, up 72.69% year-on-year [10] - Hopu Co., Ltd.'s wholly-owned subsidiary signed a 520 million yuan procurement contract for energy storage systems [10] - Daye Intelligent's wholly-owned subsidiary plans to sign a leasing contract for light ships with OOS [11] - International Composite Materials is actively advancing the construction of a new fine yarn production line, which will significantly reduce production costs for electronic fine yarn [11] - Amway's development of polyurethane composite materials for embodied intelligence scenarios is in the early exploratory stage [11] - Dongya Machinery plans to invest 400 million yuan in an intelligent manufacturing base for air compressors and core components in Central China [11] - Betta Pharmaceuticals has reached a strategic cooperation with Shengsi Bio, obtaining exclusive general agency rights for recombinant coagulation factor products [11] - Nanshan Zhishang is collaborating with Junsheng Electronics on humanoid robots, currently producing fabric materials for robot heads [11] - Tianqi Co., Ltd. has signed a strategic cooperation agreement with Foxconn Automotive, planning to deploy no less than 2,000 embodied intelligent robots internally over five years [11] - Jiangsu Leili has established stable orders with clients including Blue Technology and Zhiyuan Robotics [11] - Guansheng Co., Ltd. is advancing its solid-state battery project as planned, with an expected first-phase capacity of 2 GWh [12] - Baichuan Energy plans to acquire 22.86% equity of Xi'an Zhongke Optoelectronics for 215 million yuan, which is a company engaged in the research and production of embodied intelligent robots [12]

Core Viewpoint - Dongtu Technology plans to acquire 100% equity of Gaoweike through a combination of share issuance and cash payment, marking a significant asset restructuring and providing a new channel for Gaoweike to enter the capital market after multiple failed IPO attempts [2][3]. Group 1: Acquisition Details - The acquisition involves purchasing 100% of Gaoweike from 43 transaction parties, including Zhang Xun and Liu Xinping, and raising supporting funds by issuing shares to no more than 35 specific investors [3]. - Gaoweike specializes in industrial automation, digital comprehensive services, and the R&D, production, and sales of core products for automation control systems, serving various manufacturing sectors such as new energy batteries, photovoltaics, and automotive [3]. Group 2: Financial Performance - Gaoweike's revenue from 2020 to the first half of 2023 was 1.315 billion, 1.635 billion, 1.524 billion, and 739 million respectively, with net profits of 37.05 million, 47.28 million, 58.60 million, and 31.04 million [4]. - The company has high accounts receivable, with figures of 315 million, 398 million, and 426 million from 2020 to 2022, representing over 30% of current assets, and a bad debt of 64.91 million in 2022, accounting for 13.23% of receivables [4]. Group 3: Supplier Concentration - Gaoweike's supplier base is highly concentrated, with the top five suppliers accounting for 78.13%, 78.09%, and 78.89% of total purchases from 2020 to 2022 [5]. Group 4: Dongtu Technology's Business Strategy - Dongtu Technology, established in 2000, focuses on the R&D, production, and sales of core hardware and software technologies for industrial internet, including industrial operating systems and intelligent controllers [6]. - In 2023, Dongtu Technology has actively expanded into the fields of embodied intelligence and semiconductors, launching a robotic operating system and investing in semiconductor technology [7]. Group 5: Financial Challenges - In the first three quarters of 2025, Dongtu Technology reported revenue of 501 million, a year-on-year decline of 11.72%, and a net loss of 148 million, with negative cash flow from operating activities of 209 million [8]. - As of September 2025, the company had goodwill valued at 1.269 billion, with impairment provisions of 1.16 billion, leaving a net goodwill of only 109 million, indicating potential risks if Gaoweike's performance does not meet expectations [10].

Group 1 - Dongtu Technology plans to acquire 100% equity of Gaoweike through a combination of issuing shares and cash payment, with the transaction expected to constitute a major asset restructuring [2] - Gaoweike is a high-tech enterprise specializing in industrial automation and digital comprehensive services, providing automation control solutions across various manufacturing sectors including new energy batteries, photovoltaics, and automotive [2] - The acquisition aims to enhance the localization rate of core control technologies in high-end equipment manufacturing and to upgrade Dongtu Technology's capabilities from product provision to comprehensive solutions and systematic services [2] Group 2 - Gaoweike has attempted to go public three times since 2012, with its latest attempt in September 2023 being withdrawn in September 2024, making it a familiar entity in the A-share market [3] - From 2020 to the first half of 2023, Gaoweike's revenue figures were 1.315 billion, 1.635 billion, 1.524 billion, and 739 million respectively, with net profits of 37.05 million, 47.28 million, 58.60 million, and 31.04 million [4] - Gaoweike has high accounts receivable, with figures of 315 million, 398 million, and 426 million from 2020 to 2022, and a bad debt of 64.91 million in 2022, representing 13.23% of accounts receivable [4] Group 3 - Dongtu Technology, established in 2000, focuses on the research, production, and sales of core hardware and software technologies for industrial internet, including industrial operating systems and intelligent controllers [5] - In 2025, Dongtu Technology reported a revenue of 501 million, a year-on-year decline of 11.72%, and a net loss of 148 million, with negative cash flow from operating activities of 209 million [6] - As of September 2025, Dongtu Technology's goodwill was valued at 1.269 billion, with an impairment provision of 1.16 billion, leaving a net goodwill of 109 million, indicating potential risks if Gaoweike's performance does not meet expectations [8]

Group 1 - Dongtu Technology plans to acquire 100% equity of Gaoweike through a combination of issuing shares and cash payment, along with raising matching funds [2][3][6] - The acquisition is expected to enhance the domestic production rate of core control technologies in high-end equipment manufacturing and upgrade the company's capabilities in providing comprehensive solutions [6][10] - Gaoweike has attempted to go public three times since 2012 but has faced repeated failures, making it a familiar entity in the A-share market [6][7] Group 2 - Gaoweike's revenue from 2020 to the first half of 2023 was 1.315 billion, 1.635 billion, 1.524 billion, and 739 million respectively, with net profits of 37.05 million, 47.28 million, 58.60 million, and 31.04 million [7] - The company has high accounts receivable, with figures of 315 million, 398 million, and 426 million from 2020 to 2022, representing over 30% of current assets [7][8] - Dongtu Technology has been actively expanding its business in the fields of embodied intelligence and semiconductors, including investments in various companies and the establishment of a subsidiary [11][12] Group 3 - In the first three quarters of 2025, Dongtu Technology reported a revenue of 501 million, a year-on-year decrease of 11.72%, and a net loss of 148 million [12] - The company has a significant goodwill on its balance sheet, with a book value of 1.269 billion and an impairment provision of 1.160 billion, leaving a net amount of only 109 million [12][13] - The transaction with Gaoweike has not yet signed a clear performance compensation agreement due to ongoing auditing and evaluation work [13]

Core Insights - The A-share merger and acquisition market is experiencing a significant increase in activity, driven by favorable policies and capital empowerment for industrial transformation [1] - A total of 21 A-share listed companies disclosed merger and acquisition progress this week, indicating a robust trend in the market [1] Group 1: Mergers and Acquisitions Announcements - Dongtu Technology plans to acquire 100% of Gaoweike's shares and will resume trading on November 3 [1][5] - Baichuan Energy intends to acquire 22.86% of Xi'an Zhongke Optoelectronics for 215 million yuan [1] - Weigao Blood Purification is set to acquire 100% of Weigao Purui Medical Packaging, with trading resuming on November 3 [1][3] - Anfu Technology plans to acquire 6.7402% of Anfu Energy for 304 million yuan [1] - Pengding Holdings aims to acquire and increase investment in Wuxi Huayang Technology for 357 million yuan [1] - Sichuan Jinding is acquiring 50% of Sichuan Kaiwu Qiyuan Technology [1] - Shahe Co. is planning to purchase 70% of Jinghua Electronics [1] - Kaineng Health intends to acquire all shares and assets of certain subsidiaries of Yuanneng Group in cash [1] - Huali Co. plans to acquire 51% of Zhongke Huilian [1] - Keda Co. aims to acquire at least 60% of Hanhua Paper [1] - Jiuzhitang plans to acquire 35% of Jixianglong Biotechnology for 21 million yuan [1] - Lingyi Zhi Manufacturing intends to acquire 96.15% of Zhejiang Xianglong for 2.404 billion yuan [1] - Kanglong Chemical plans to acquire 82.54% of Bai'ao De for 1.346 billion yuan [1] - COSCO Shipping Energy intends to acquire 100% of Shanghai Liquefied Gas for 598 million yuan [1] - Jixin Technology plans to acquire 57.4531% of New Energy Bearings in cash [1] - Victory Co. is planning to acquire gas-related assets controlled by its major shareholder [2][6] - Guangyun Da intends to acquire control of Lingxuan Precision in cash [2] - New Xing Casting plans to acquire 10% of Fukang Energy for 151 million yuan [2] - Boyuan Chemical intends to acquire 10.65% of Yingen Mining for 2.726 billion yuan [2] - Delisi plans to acquire 100% of Yufenghe Food for 32.32 million yuan [2] Group 2: Strategic Importance of Acquisitions - Weigao Purui, established in 2018, is the first domestic company to obtain a pre-filled syringe registration certificate, indicating its strategic importance in the pharmaceutical packaging sector [4] - The acquisition by Weigao Blood Purification is a key step in enhancing its industrial chain layout, allowing for expansion into the pharmaceutical packaging field [4] - Dongtu Technology's acquisition of Gaoweike aims to enhance domestic core control technology in high-end equipment manufacturing and upgrade its service model [5] - Victory Co.'s planned acquisition of gas-related assets is expected to optimize its asset structure and enhance its market position [6]

Core Viewpoint - The acquisition of 100% shares of Highwei Technology by Dongtu Technology signifies a strategic integration in China's industrial technology sector, reflecting a shift from policy-driven to market-driven innovation in the industrial software industry [2][4][7]. Group 1: Strategic Integration - The merger combines Dongtu Technology's expertise in industrial networks and intelligent control platforms with Highwei Technology's extensive service network in key sectors like new energy and semiconductors, creating a unique path for technology transformation [4][6]. - This integration allows Dongtu Technology to rapidly adapt its intelligent control technology to thousands of manufacturing scenarios through Highwei Technology's industry experience [4][7]. - The acquisition provides Dongtu Technology with real-time application data from thousands of manufacturing clients, which will serve as a vital resource for technology iteration and address the challenges of domestic industrial software usability [4][6]. Group 2: Industry Safety and Innovation - The merger is positioned as a response to national needs for industrial chain security, particularly in strategic emerging industries such as new energy vehicles and photovoltaic equipment, where safety in control systems is critical [6][7]. - This integration model demonstrates a significant example of how application-driven innovation can enhance the autonomy of key industries in China, moving from reliance on imports to developing domestic capabilities [7][8]. Group 3: New Valuation Logic - The transaction introduces a new dimension to the valuation of technology companies, emphasizing the importance of factors beyond traditional financial metrics, such as potential market share in a market with less than 10% domestic replacement rate and the ability to construct closed-loop ecosystems [10][11]. - This multi-dimensional evaluation framework encourages capital to focus on companies with systemic solution capabilities and potential for building industrial ecosystems, fostering a healthier innovation environment [10][12]. - The merger is seen as a pivotal moment in the evolution of industrial innovation in China, marking the transition to a new phase of industry integration and the exploration of market-driven paths for technological advancement [10][11].

Core Insights - The acquisition of 100% shares of Gaoweike by Dongtu Technology signifies a strategic integration in China's industrial technology sector, reflecting a shift from policy-driven to market-driven innovation in the industrial software industry [1][5]. Group 1: Strategic Integration - The merger combines Dongtu Technology's expertise in industrial networks and intelligent control platforms with Gaoweike's extensive channel network in key sectors like renewable energy and semiconductors, creating a robust foundation for technology application [2]. - This integration establishes a unique technology transformation pathway, leveraging market demand to adapt Dongtu's technology across thousands of manufacturing scenarios and utilizing real-time application data from Gaoweike's clients to enhance technology iteration [3]. Group 2: Industry Safety and Innovation - The merger addresses national strategic needs by integrating self-controlled technology into critical sectors such as new energy vehicles and photovoltaic equipment, which require high safety standards for control systems [4]. - This model of integration serves as a demonstration effect, potentially enhancing the self-sufficiency of China's manufacturing sector by driving core technology breakthroughs through downstream application demands [4]. Group 3: Market Evolution - The acquisition represents a significant transition in China's industrial innovation landscape, moving from a phase of policy guidance to one focused on market competition and technology commercialization [5]. - Dongtu Technology's actions align with national goals to secure key technologies domestically, emphasizing the importance of market-driven approaches in promoting the adoption of intelligent control technologies [5]. Group 4: New Valuation Logic - The transaction introduces a multi-dimensional valuation model for technology companies, incorporating strategic factors such as potential market share in a low domestic replacement rate environment, integration capabilities, and contributions to national security [7]. - This new evaluation framework encourages capital to focus on companies with comprehensive solutions and ecosystem-building potential, fostering a healthier innovation ecosystem and driving industry upgrades [7]. Group 5: Collaborative Innovation - The integration highlights the importance of collaboration in driving technological breakthroughs and innovation, suggesting that capital can significantly empower industrial innovation in the current era [8].